EPIGENESISPHARMACEUTICALS.COM
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

EPIGENESISPHARMACEUTICALS.COM Trademark

Serial Number: 76360212

EPIGENESISPHARMACEUTICALS.COM is a trademark filed by EPIGENESIS Pharmaceuticals, Inc. on January 7, 2002. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

EPIGENESIS Pharmaceuticals, Inc. (26 trademarks)

2055 East Park
Cranbury, NJ 08512

Entity Type: 03

Epigenesis Pharmaceuticals, LLC (13 trademarks)

2009 Eastpark Boulevard
Cranbury, NJ 08512

Entity Type: 16

Trademark Details

Filing Date

January 7, 2002

Registration Date

Not Registered

Published for Opposition

April 8, 2003

Goods & Services

medical diagnostic and therapeutic preparations and devices for administering same, sold filled with diagnostic and therapeutic preparations or separately as a kit, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled or separately as a kit, the preparations including polynucleotides, proteins and/or organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms,; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc., as well as all metastatic cancers, e.g.; cancers which metastasized to the lung(s), breast, liver and prostate included

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 7, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 7, 2006 ABN6
SOU EXTENSION 5 GRANTED
Dec 29, 2005 EX5G
SOU EXTENSION 5 FILED
Dec 29, 2005 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 29, 2005 EEXT
SOU EXTENSION 4 GRANTED
Jul 1, 2005 EX4G
SOU EXTENSION 4 FILED
Jul 1, 2005 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 1, 2005 EEXT
SOU EXTENSION 3 GRANTED
Jan 10, 2005 EX3G
SOU EXTENSION 3 FILED
Dec 23, 2004 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 23, 2004 EEXT
SOU EXTENSION 2 GRANTED
Jul 28, 2004 EX2G
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 19, 2004 TCCA
PAPER RECEIVED
Jul 16, 2004 MAIL
CASE FILE IN TICRS
Jul 12, 2004 CFIT
SOU EXTENSION 2 FILED
Jun 30, 2004 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 30, 2004 EEXT
SOU EXTENSION 1 GRANTED
Jan 22, 2004 EX1G
SOU EXTENSION 1 FILED
Dec 31, 2003 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 31, 2003 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2003 NOAM
PUBLISHED FOR OPPOSITION
Apr 8, 2003 PUBO
NOTICE OF PUBLICATION
Mar 19, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2003 CNSA
Sec. 1(B) CLAIM ADDED
Oct 25, 2002 1.BA
SEC. 1(A) CLAIM DELETED
Oct 25, 2002 1.AD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2002 CRFA
PAPER RECEIVED
Oct 25, 2002 MAIL
NON-FINAL ACTION MAILED
Apr 26, 2002 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2002 DOCK
ASSIGNED TO EXAMINER
Apr 4, 2002 DOCK